Skip to main content

Dr. Julia Lewis, MD

Nephrology (Kidney) (Nephrology Physician)

  • Medicare participating

At a glance

Years since graduation
46
In the NPI registry since
2006
Medicare patients seen, 2024
326

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1980Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Nephrology Physician primary
    TN license MD16829

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Nephrology (Kidney) per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
326
Services billed
1,120
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes267104
Established patient office or other outpatient visit, 30-39 minutes193122
Dialysis services, 4 or more physician visits per month (20 years or older)16329
Home dialysis services per month (20 years or older)12020
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes8785
Hemodialysis procedure with physician evaluation5424
Dialysis procedure requiring repeat evaluation4517
Established patient office or other outpatient visit, 40-54 minutes3829
Dialysis services, 2-3 physician visits per month (20 years or older)3014
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes2013

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 4 companies reported 8 payments worth $19,681 in total to this clinician.

By company
Travere Therapeutics, Inc.$13,223
Ipsen Biopharmaceuticals, Inc$5,575
Biogen, Inc.$750
Calliditas Therapeutics US Inc.$132
By type
Consulting Fee$18,675
Travel and Lodging$873
Food and Beverage$132

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 2, 2025Travere Therapeutics, Inc.
Sep 2, 2025
Consulting Fee$9,100
May 23, 2025Travere Therapeutics, Inc.
May 23, 2025
Consulting Fee$3,250
May 14, 2025Ipsen Biopharmaceuticals, Inc
May 14, 2025
Consulting Fee$3,020
Jun 4, 2025Ipsen Biopharmaceuticals, Inc
Jun 4, 2025
Consulting Fee$1,800
Sep 2, 2025Travere Therapeutics, Inc.
Sep 2, 2025
Travel and Lodging
travel to san diego, CA · in-kind
$873
May 14, 2025Ipsen Biopharmaceuticals, Inc
May 14, 2025
Consulting Fee$755
Jun 12, 2025Biogen, Inc.
Jun 12, 2025
Consulting Fee$750

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Tennessee →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,723 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
    Vertex Pharmaceuticals Incorporated

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Nephrology (Kidney) clinicians in Nashville

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 16, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1992897326. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.